###begin article-title 0
###xml 83 93 80 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
Abeta42 Mutants with Different Aggregation Profiles Induce Distinct Pathologies in Drosophila
###end article-title 0
###begin p 1
Conceived and designed the experiments: KI KI-A. Performed the experiments: IH KI HC SH AL KI-A AG LG CS. Analyzed the data: YZ KI HC SH KI-A. Contributed reagents/materials/analysis tools: KI. Wrote the paper: YZ KI KI-A.
###end p 1
###begin p 2
###xml 678 681 660 663 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arc</underline>
###xml 702 705 681 684 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arc</underline>
###xml 714 717 693 696 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">art</underline>
###xml 742 745 718 721 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">art</underline>
###xml 809 817 782 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 826 836 799 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1835 1842 1763 1770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 567 572 <span type="species:ncbi:9606">human</span>
Aggregation of the amyloid-beta-42 (Abeta42) peptide in the brain parenchyma is a pathological hallmark of Alzheimer's disease (AD), and the prevention of Abeta aggregation has been proposed as a therapeutic intervention in AD. However, recent reports indicate that Abeta can form several different prefibrillar and fibrillar aggregates and that each aggregate may confer different pathogenic effects, suggesting that manipulation of Abeta42 aggregation may not only quantitatively but also qualitatively modify brain pathology. Here, we compare the pathogenicity of human Abeta42 mutants with differing tendencies to aggregate. We examined the aggregation-prone, EOFAD-related Arctic mutation (Abeta42Arc) and an artificial mutation (Abeta42art) that is known to suppress aggregation and toxicity of Abeta42 in vitro. In the Drosophila brain, Abeta42Arc formed more oligomers and deposits than did wild type Abeta42, while Abeta42art formed fewer oligomers and deposits. The severity of locomotor dysfunction and premature death positively correlated with the aggregation tendencies of Abeta peptides. Surprisingly, however, Abeta42art caused earlier onset of memory defects than Abeta42. More remarkably, each Abeta induced qualitatively different pathologies. Abeta42Arc caused greater neuron loss than did Abeta42, while Abeta42art flies showed the strongest neurite degeneration. This pattern of degeneration coincides with the distribution of Thioflavin S-stained Abeta aggregates: Abeta42Arc formed large deposits in the cell body, Abeta42art accumulated preferentially in the neurites, while Abeta42 accumulated in both locations. Our results demonstrate that manipulation of the aggregation propensity of Abeta42 does not simply change the level of toxicity, but can also result in qualitative shifts in the pathology induced in vivo.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 196 199 190 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Selkoe1">[1]</xref>
###xml 289 292 280 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Thal1">[2]</xref>
###xml 400 403 388 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Tanzi1">[3]</xref>
###xml 478 481 463 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Nilsberth1">[4]</xref>
###xml 483 486 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Johansson1">[5]</xref>
###xml 569 572 551 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Lansbury1">[6]</xref>
###xml 667 670 646 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Gestwicki1">[7]</xref>
The amyloid-beta-42 (Abeta42) peptide has been suggested to play a central role in the pathogenesis of Alzheimer's disease (AD), a devastating, and currently incurable, neurodegenerative disorder [1]. Aggregation of Abeta42 peptide in the brain parenchyma is a pathological hallmark of AD [2]. Genetic studies of early-onset familial AD (EOFAD) provide a strong causative link between Abeta42 and AD [3], and some mutations in the Abeta peptide promote amyloid fibril formation [4], [5]. These data suggest that Abeta42 aggregation might be involved in AD pathogenesis [6], and Abeta42 aggregation is therefore an attractive target for therapeutic intervention in AD [7].
###end p 4
###begin p 5
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 107 110 101 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Yankner1">[8]</xref>
###xml 112 115 106 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Murakami1">[9]</xref>
###xml 423 427 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Caughey1">[10]</xref>
###xml 428 432 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Slow1">[13]</xref>
###xml 497 504 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
In vitro, the neurotoxicity of Abeta42 has been often correlated with the tendency of Abeta42 to aggregate [8], [9]. However, recent evidence indicates that Abeta42 can form a variety of misfolded structures, including multiple monomer conformers, different types of prefibrillar assemblies, and structurally distinct amyloid fibrils, and that such structural polymorphisms may mediate the diverse toxic effects of Abeta42 [10]-[13]. These results suggest that manipulation of Abeta42 aggregation in vivo may not simply change the magnitude of toxicity, but also qualitatively modify its pathogenic effects.
###end p 5
###begin p 6
###xml 73 83 70 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 206 210 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Iijima1">[14]</xref>
###xml 571 578 553 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
We have previously shown that expression of the human Abeta42 peptide in Drosophila brains induces age-dependent memory defects, locomotor dysfunction, and neurodegeneration accompanied by Abeta42 deposits [14]. Using this model system, we investigated the correlation between the aggregation tendencies of Abeta42 and memory defects, as well as neurodegeneration, through genetic manipulation of Abeta42 aggregation. We demonstrated that manipulation of the aggregation propensity of Abeta42 qualitatively as well as quantitatively modified the pathogenicity of Abeta42 in vivo.
###end p 6
###begin title 7
Results and Discussion
###end title 7
###begin p 8
###xml 27 30 24 27 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arc</underline>
###xml 70 73 64 67 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arc</underline>
###xml 76 85 70 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1A</xref>
###xml 133 136 127 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Nilsberth1">[4]</xref>
###xml 174 182 168 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 182 185 176 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Johansson1">[5]</xref>
###xml 187 191 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Whalen1">[15]</xref>
###xml 273 277 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Cheng1">[16]</xref>
###xml 279 283 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Lord1">[17]</xref>
###xml 301 304 295 298 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">art</underline>
###xml 349 352 340 343 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">art</underline>
###xml 355 364 346 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1A</xref>
###xml 416 424 407 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 424 427 415 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Murakami1">[9]</xref>
###xml 429 433 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Morimoto1">[18]</xref>
###xml 484 494 475 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. elegans</italic>
###xml 502 506 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Fay1">[19]</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 484 494 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
The human Abeta42 with the Arctic mutation (E22G substitution, Abeta42Arc) (Figure 1A), which causes early onset familial AD (EOFAD) [4], is more aggregation-prone and toxic in vitro[5], [15] and accelerates the formation of amyloid deposits in the brains of AD model mice [16], [17]. In contrast, an artificial mutation, (L17P substitution, Abeta42art) (Figure 1A), suppresses amyloid fibril formation and toxicity in vitro[9], [18] and prevents the formation of amyloid deposits in C. elegans muscle [19].
###end p 8
###begin title 9
Expression, distribution, aggregation, and accumulation profiles of mutant Abeta42 peptides in fly brains.
###end title 9
###begin p 10
###xml 332 340 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s009">Table S1</xref>
###xml 422 426 404 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c155</sup>
###xml 413 426 395 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">elav-Gal4<sup>c155</sup></italic>
A, Sequences of Abeta42, Abeta42Arc, and Abeta42art. B, Expression levels of Abeta in independent transgenic lines (W; weak, M; moderate, S: strong expression) at 1-2dae (top panel, Abeta42), when accumulation of each Abeta in the insoluble fraction was minimum, were compared, and relative ratios were shown below each lane and in Table S1 (n = 3). Asterisks indicate the fly lines primarily used in this study. elav-Gal4c155 flies were used as control. Tubulin was used as a loading control (bottom panel: Tu). C, ImmunoEM detection of Abeta42 in the endoplasmic reticulum (ER) and Golgi, as well as a lysosome. Gold particles are absent in the control (Control). N: nucleus, Scale bar: 1 microm. Neurons in Kenyon cell region of Abeta42 fly brains at 25dae were analyzed. D, Detection of dimers (di), trimers (tri) and tetramers (tet) in fly brains. The level of each oligomer was shown as a ratio relative to that of Abeta42. Asterisks indicate significant differences from Abeta42 (n = 3, P<0.05, Student's t-test). E, Age-dependent accumulation of Abeta peptides in detergent-soluble and insoluble fractions. The ages of the flies are indicated at the bottom.
###end p 10
###begin p 11
###xml 60 64 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Iijima1">[14]</xref>
###xml 151 162 148 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UAS-A&#946;42</italic>
###xml 164 178 158 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UAS-A&#946;42Arc</italic>
###xml 183 197 174 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UAS-A&#946;42art</italic>
###xml 304 308 289 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c155</sup>
###xml 295 308 280 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">elav-Gal4<sup>c155</sup></italic>
###xml 316 320 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Brand1">[20]</xref>
###xml 328 337 313 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">elav-Gal4</italic>
A signal sequence was fused to the N-terminus of each Abeta [14], to target the peptide to the secretory pathway. Multiple transgenic lines carrying a UAS-Abeta42, UAS-Abeta42Arc, or UAS-Abeta42art transgene were established. Expression of each Abeta in the brain was driven by the pan-neuronal elav-Gal4c155 driver [20]. Since elav-Gal4 is on the X chromosome, male progeny expressed more Abeta peptide and developed stronger phenotypes than female progeny due to dosage compensation (data not shown). The results presented in this study are from male flies, unless otherwise indicated.
###end p 11
###begin p 12
###xml 104 113 95 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1B</xref>
###xml 234 249 219 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1B and D</xref>
###xml 445 457 421 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s001">Figure S1A&#8211;C</xref>
###xml 586 595 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1C</xref>
###xml 850 860 811 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 877 886 838 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s002">Figure S2</xref>
###xml 897 907 858 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1087 1096 1042 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s003">Figure S3</xref>
Western blot analysis detected monomeric forms of Abeta42, Abeta42Arc, and Abeta42art as 4 kDa signals (Figure 1B). Monomeric and oligomeric forms of Abeta42art migrated slower than those of Abeta42 due to an amino acid substitution (Figure 1B and D). Immunoprecipitation followed by mass spectrometry analysis confirmed that the fused signal peptide was correctly cleaved, and intact Abeta42, Abeta42Arc, and Abeta42art peptides were produced (Figure S1A-C). Immuno-electron microscopy (Immuno-EM) detected Abeta42 signals in the secretory pathway, including ER, Golgi, and lysosomes (Figure 1C), with minimal signals in the mitochondria and cytoplasm of neurons in the Kenyon cell region of Abeta42 fly brains. Abeta42Arc and Abeta42art peptides were also detected in the secretory pathway (data not shown). Secretion of Abeta peptides occurred in Drosophila cultured cells (Figure S2), and, in Drosophila brains, immuno-EM analysis occasionally detected Abeta42 accumulation in glial cells suggesting that Abeta42 peptides were secreted from neurons and then taken up by glial cells (Figure S3).
###end p 12
###begin p 13
###xml 206 215 203 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s004">Figure S4</xref>
###xml 220 228 217 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s009">Table S1</xref>
###xml 292 301 289 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1B</xref>
###xml 412 422 406 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
All Abeta peptides caused late-onset locomotor defects and premature death when expressed in neurons. Since the severity of these phenotypes positively correlated with the expression level of the peptides (Figure S4 and Table S1), we selected transgenic lines with similar expression levels (Figure 1B, asterisks) to characterize the accumulation profiles and the pathogenic effects of each Abeta peptide in the Drosophila brain.
###end p 13
###begin p 14
###xml 189 198 186 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1D</xref>
###xml 483 487 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Kayed1">[21]</xref>
###xml 591 600 567 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s005">Figure S5</xref>
###xml 696 705 666 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1E</xref>
###xml 796 805 766 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1E</xref>
###xml 928 937 892 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1E</xref>
###xml 1139 1148 1094 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1E</xref>
###xml 1541 1548 1481 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
To compare the ability of each Abeta peptide to form small oligomers, we quantified the levels of dimers (8 kDa), trimers (12 kDa), and tetramers (16 kDa), as detected by Western blotting (Figure 1D). This analysis revealed that Abeta42Arc formed 2-fold more dimers and trimers than did Abeta42, while Abeta42art formed 50% fewer dimers and tetramers. We also tested whether higher molecular weight Abeta oligomers were formed in fly brains with dot blot analysis using A11 antibody [21]. We did not observe A11-positive oligomers in any of Abeta42Arc, Abeta42 and Abeta42art brain lysates (Figure S5). During aging, Abeta42 and Abeta42Arc accumulated in the insoluble fraction of brain lysates (Figure 1E; extracted by 70% formic acid), with no significant accumulation in the soluble fraction (Figure 1E; extracted by RIPA/1%SDS). Accumulation of Abeta42Arc in the insoluble fraction was more aggressive than that of Abeta42 (Figure 1E, compare Abeta42 and Abeta42Arc in 5 days-after-eclosion (dae) flies). In contrast, Abeta42art strongly accumulated in the soluble fraction with greatly reduced accumulation in the insoluble fraction (Figure 1E). It should be noted that although age-dependent accumulation of Abeta42Arc in FA fraction from 5 to 25dae was clearly observed, the level of Abeta42Arc at 35dae was less than that at 25dae, presumably due to a progressive cell loss in Abeta42Arc fly brains (See below). These results demonstrate that Abeta42Arc is consistently more, and Abeta42art is significantly less, prone to aggregate in vivo.
###end p 14
###begin p 15
###xml 220 224 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Ganetzky1">[22]</xref>
###xml 357 366 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g002">Figure 2A</xref>
###xml 606 615 582 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g002">Figure 2B</xref>
The severity of locomotor dysfunction and premature death phenotypes of the transgenic flies correlated well with the aggregation proneness of the Abeta peptides. Climbing ability was used to quantify locomotor activity [22]. Climbing disability in 80% of the flies occurred by 25, 35, and 45 dae in Abeta42Arc, Abeta42, and Abeta42art flies, respectively (Figure 2A). A similar tendency was observed for the premature death phenotype. The average lifespan of Abeta42Arc flies (32.9 dae) was shorter than that of Abeta42 flies (46.2 dae), while Abeta42art flies (51.4 dae) lived longer than Abeta42 flies (Figure 2B).
###end p 15
###begin title 16
Behavioral defects in Abeta42, Abeta42Arc, and Abeta42art flies.
###end title 16
###begin p 17
A, Locomotor dysfunction. The percent of flies at the top (yellow), middle (magenta) or bottom (blue) of the vial at 10 seconds after knocking flies to the bottom are shown (average+/-SEM (n = 10)). B, Premature death. The percent survivorship was plotted against the age (dae). C and D, Memory defects. One hour memory was assessed by Pavlovian olfactory conditioning at 5 dae (C) and 10 dae (D). Asterisks indicate a significant difference from control (n = 6 or 8, alpha<0.05, Tukey-Kramer significant difference). Average memory scores+/-SEM are shown.
###end p 17
###begin p 18
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Tully1">[23]</xref>
###xml 236 245 236 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g002">Figure 2A</xref>
###xml 630 639 621 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g002">Figure 2C</xref>
###xml 721 730 709 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g002">Figure 2C</xref>
###xml 842 851 827 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g002">Figure 2D</xref>
###xml 992 1001 968 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g002">Figure 2D</xref>
###xml 1120 1129 1096 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s006">Figure S6</xref>
###xml 1379 1383 1349 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Selkoe2">[24]</xref>
###xml 1517 1525 1487 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s010">Table S2</xref>
###xml 1344 1352 <span type="species:ncbi:9606">patients</span>
However, the onset of memory defects measured by Pavlovian olfactory classical conditioning [23] did not follow this simple trend. This assay was conducted with younger flies (5 or 10 dae), before the flies developed locomotor defects (Figure 2A). Data obtained from male and female flies are presented separately, since expression of Abeta is higher in males than in females, as a result of dosage compensation. For 5 dae flies in both male and female groups, Abeta42Arc flies showed the most severe 1 hour memory defects (memory scores were measured 1 hour after the training session), and Abeta42art flies were also defective (Figure 2C). In contrast, memory in Abeta42 flies was indistinguishable from control flies (Figure 2C). For 10 dae flies, all Abeta flies reached a similar level of memory defects in the male group (left panel in Figure 2D). In the female group, memory scores remained the lowest in Abeta42Arc flies, and both Abeta42art and Abeta42 flies showed similar defects (Figure 2D). A similar tendency was observed with the learning assay (learning scores were obtained immediately after training) (Figure S6). Of note, learning scores were normal in both 10 dae Abeta42 and Abeta42art female flies, indicating that these flies were specifically defective in short-term memory, the major clinical manifestation observed in patients in the early stages of AD [24]. The sensory motor activity of the flies, including sensing odors and electric shock, was indistinguishable from controls at 10 dae (Table S2), indicating that the observed defects can be interpreted as learning and memory defects.
###end p 18
###begin p 19
###xml 408 412 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Heisenberg1">[25]</xref>
###xml 550 562 529 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g003">Figures 3A&#8211;F</xref>
###xml 643 655 619 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g003">Figures 3A&#8211;F</xref>
###xml 866 876 836 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OK107-gal4</italic>
###xml 982 986 952 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Watts1">[26]</xref>
###xml 988 997 958 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g003">Figure 3G</xref>
###xml 1191 1202 1155 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g003">Figure 3G&#8211;I</xref>
###xml 1336 1345 1294 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s007">Figure S7</xref>
Remarkably, Abeta42, Abeta42Arc, and Abeta42art each induced distinct pathologies. Neurodegeneration in the Abeta fly brains was observed as a vacuolar appearance both in the cell body and neuropil regions. To quantify the area lost in these regions, we focused on the mushroom body structure, in which the cell bodies (Kenyon cell body), dendrites (Calyxes), and axon bundles (Lobes) were easily identified [25]. Our analysis revealed that, at 25 dae, Abeta42Arc fly brains showed more extensive cell loss than that in Abeta42 or Abeta42art brains (Figures 3A-F). However, the level of neuropil degeneration was greatest in Abeta42art flies (Figures 3A-F). The enhanced neuropil degeneration observed in Abeta42art flies was further confirmed by confocal analysis. In this assay, each Abeta42 peptide was preferentially expressed in mushroom body neurons using the OK107-gal4 driver, and the structure of dendrites (Calyxes) and axons (Lobes) was visualized by co-expressed CD8-GFP[26] (Figure 3G). Quantification of the size of these structures revealed that Abeta42art induced earlier onset and more severe atrophy in both the dendrites (Calyxes) and axons (Lobes) among all Abeta flies (Figure 3G-I). The severity of the atrophy in Abeta42 and Abeta42Arc was similar. Observed differences were not due to differences in brain size (Figure S7).
###end p 19
###begin title 20
Cell body and neuropil degeneration in Abeta42, Abeta42Arc, and Abeta42art flies.
###end title 20
###begin p 21
A-E, Neurodegeneration in Abeta flies at 25 dae. The cell body and neuropil region in the mushroom body are enlarged. Arrowheads indicate neurodegeneration (C to E). F, Percentage of the area lost in the cell body (green) and neuropil (magenta) regions are shown as averages+/-SEM (n = 7-9 hemispheres). Asterisks indicate significant differences from Abeta42 (P<0.05, Student's t-test). G, Atrophy of Calyxes (dendrites) and Lobes (axons) in Abeta flies. H and I, Areas of Calyxes and Lobes were measured as indicated in (G) and presented as averages+/-SEM (n = 6 hemispheres). Asterisks indicate significant differences from control (P<0.05, Student's t-test). The ages of the flies are indicated at the bottom.
###end p 21
###begin p 22
###xml 324 336 306 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g004">Figure 4E, F</xref>
###xml 416 428 395 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g004">Figure 4G, H</xref>
###xml 549 561 525 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g004">Figure 4C, D</xref>
###xml 676 685 649 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g004">Figure 4K</xref>
###xml 742 751 715 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s008">Figure S8</xref>
Immunostaining and Thioflavin S (TS) staining, which labels aggregated Abeta42, revealed that the degenerated structures in Abeta42, Abeta42Arc, and Abeta42art flies were closely correlated with the intraneuronal accumulation sites of each Abeta peptide. Abeta42Arc accumulated primarily in the cell soma as large deposits (Figure 4E, F, arrowheads in F), while Abeta42art was distributed primarily in the neurites (Figure 4G, H, arrows in H). Abeta42 was detected both in the cell body and in the neurites, but to a lesser extent than the mutants (Figure 4C, D, arrowheads and arrows in D). Quantification of TS-positive deposits and neurites in Abeta fly brains is shown in Figure 4K. These fly brains were negative for Congo-Red staining (Figure S8), and no intraneuronal amyloid fibrils were observed by electron microscopy, suggesting that the majority of TS-positive aggregates did not contain amyloid fibril structures. These distinct patterns of neurodegeneration and Abeta accumulation were confirmed in several independent transgenic lines (data not shown).
###end p 22
###begin title 23
Distribution and aggregation of Abeta42, Abeta42Arc, and Abeta42art peptides in fly brains.
###end title 23
###begin p 24
A,C,E,G and I, Immunostaining of brains of 25 dae flies with anti-Abeta antibody (green). In (A), nuclei were stained with propidium iodide (magenta). B,D,F,H and J, Thioflavin S (TS) staining of brains of 25 dae flies. Arrowheads and arrows indicate TS-positive deposits and neurites, respectively. No signal was detected in the control (I, J). Scale bar in J: 50 microm. (C) and (D) are enlarged images of the boxed regions in (A) and (B), respectively. K, Numbers of TS-positive deposits and neurites were presented as averages+/-SD (n = 6 hemispheres). Asterisks indicate significant differences from Abeta42 (P<0.05, Student's t-test).
###end p 24
###begin p 25
###xml 116 123 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 353 361 344 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g002">Figure 2</xref>
###xml 433 436 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Nilsberth1">[4]</xref>
###xml 511 518 496 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 713 721 695 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g002">Figure 2</xref>
###xml 1085 1093 1058 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g003">Figure 3</xref>
###xml 1098 1099 1071 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g004">4</xref>
###xml 1183 1187 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Ryman1">[27]</xref>
This study highlights that the complex toxicities of Abeta42 are associated with different aggregation propensities in vivo. First, the increase in Abeta42 aggregation proneness associated with the pathogenic Arctic mutation (E22G) correlated with more severe detrimental effects on memory, locomotor ability, and lifespan than those caused by Abeta42 (Figure 2). These data are consistent with the fact that Abeta42Arc causes EOFAD [4], and indicates that aggregation proneness contributes to Abeta42 toxicity in vivo. Second, an artificial mutation (L17P) that decreased Abeta42 aggregation proneness suppressed the toxicities toward locomotor function and lifespan, but caused earlier onset of memory defects (Figure 2), showing that not all pathogenic effects of Abeta42 correlate directly with aggregation proneness. Third, the differences in aggregation tendencies of Abeta42 and derivatives correlated with qualitative shifts in pathology in the fly brain, exemplified by distinct neurodegeneration patterns accompanying the different accumulation profiles of Abeta42 peptides (Figure 3 and 4). Importantly, these differences are not due to a difference in genetic background [27], since these Abeta flies were generated in the same genetic background.
###end p 25
###begin p 26
###xml 231 235 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Small1">[28]</xref>
###xml 245 255 235 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 311 315 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Greeve1">[29]</xref>
###xml 624 633 605 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1C</xref>
###xml 635 637 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s002">S2</xref>
###xml 642 644 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s003">S3</xref>
###xml 744 748 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Small1">[28]</xref>
###xml 903 907 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Busciglio1">[30]</xref>
###xml 908 912 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Cruz1">[35]</xref>
Under physiological conditions, the Abeta42 peptides are generated from amyloid precursor protein (APP) by beta- and gamma-secretases in the secretory pathway including, the transgolgi-network, endosome-system, and plasma membrane [28]. Because Drosophila has no or very low endogeneous beta-secretase activity [29], we used the artificial expression system to achieve high expression levels of Abeta42 in fly brains. In our transgenic flies, Abeta42 peptides were expressed in the ER and distributed to the late secretory pathway compartments, axons, dendrites, and presynaptic terminals, as well as secreted from neurons (Figure 1C, S2 and S3). Although the ER is not a major cellular site for Abeta generation under physiological conditions [28], several lines of evidence suggest that, under abnormal conditions, Abeta may be generated, retained, or recycled back to the ER and may induce ER stress [30]-[35]. Our fly models may recapitulate neuronal dysfunction and degeneration induced by such abnormal intracellular metabolisms of Abeta42. It would be also important to examine the effects of the Arctic (E22G) and artificial (L17P) mutations on intracellular distribution and toxicities of Abeta42 generated from the full-length APP.
###end p 26
###begin p 27
###xml 351 355 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Kelly1">[36]</xref>
###xml 357 361 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Rochet1">[37]</xref>
###xml 420 424 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-DeMattos1">[38]</xref>
###xml 440 444 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Cherny1">[39]</xref>
###xml 464 468 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Cohen1">[40]</xref>
###xml 573 577 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Cummings1">[41]</xref>
###xml 654 662 639 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 662 666 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Petkova1">[12]</xref>
###xml 671 678 656 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 678 682 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-MeyerLuehmann1">[42]</xref>
In summary, our results lead us to predict two issues. First, the partial prevention of Abeta42 amyloidgenesis by aggregation inhibitors may result in qualitative shifts in the pathogenic effects of Abeta42. Second, the tendency of Abeta42, a natively unfolded polypeptide consist primarily of random-coil structure in their native and soluble states [36], [37], to aggregate may be affected by a combination of genetic [38], environmental [39], and aging factors [40], and the resultant Abeta42 conformers or species may contribute to the heterogeneous pathogenesis of AD [41]. The existence of different "Abeta species" has been recently verified both in vitro[12] and in vivo[42].
###end p 27
###begin title 28
Materials and Methods
###end title 28
###begin title 29
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
Drosophila genetics and stocks
###end title 29
###begin p 30
###xml 195 205 186 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 271 275 262 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1118</sup>
###xml 270 275 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w<sup>1118</sup></italic>
###xml 277 283 268 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">isoCJ1</italic>
###xml 497 516 479 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UAS-CD8::GFP;;OK107</italic>
###xml 554 558 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Watts1">[26]</xref>
###xml 560 570 542 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UAS-nlsGFP</italic>
###xml 584 588 566 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c155</sup>
###xml 575 588 557 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">elav-GAL4<sup>c155</sup></italic>
###xml 630 640 612 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 706 710 688 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c155</sup>
###xml 697 710 679 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">elav-GAL4<sup>c155</sup></italic>
###xml 737 741 719 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1118</sup>
###xml 736 741 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w<sup>1118</sup></italic>
###xml 743 749 725 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">isoCJ1</italic>
###xml 867 871 849 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c155</sup>
###xml 858 873 840 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">elav-GAL4<sup>c155</sup>/Y</italic>
###xml 893 897 872 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c155</sup>
###xml 884 915 863 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">elav-GAL4<sup>c155</sup>/Y;; UAS-A&#946;42/+</italic>
###xml 938 942 911 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c155</sup>
###xml 929 963 902 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">elav-GAL4<sup>c155</sup>/Y;; UAS-A&#946;42Arc/+</italic>
###xml 989 993 956 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c155</sup>
###xml 980 1014 947 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">elav-GAL4<sup>c155</sup>/Y;; UAS-A&#946;42art/+</italic>
###xml 1019 1037 983 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g003">figure 3G, H and I</xref>
###xml 1081 1108 1045 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w/Y;UAS-CD8::GFP/+;;OK107/+</italic>
###xml 1119 1160 1080 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w/Y; UAS-CD8::GFP/+;UAS-A&#946;42/+;OK107/+</italic>
###xml 1174 1218 1129 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w/Y; UAS-CD8::GFP/+;UAS-A&#946;42Arc/+;OK107/+</italic>
###xml 1235 1279 1184 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w/Y; UAS-CD8::GFP/+;UAS-A&#946;42art/+;OK107/+</italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 135 138 <span type="species:ncbi:10116">rat</span>
cDNA fragments encoding the human Abeta42, Abeta42Arc, and Abeta42art peptides were amplified by PCR from human APP cDNA, fused to the rat pre-proenkephalin signal peptide, cloned into the pUAST Drosophila transformation vector and microinjected into fly embryos of the w1118 (isoCJ1) genotype. Several transgenic lines for each Abeta construct were established. The flies were raised and maintained at 25degreesC, under conditions of 70% humidity and a 12 h:12 h light:dark cycle. The transgenic UAS-CD8::GFP;;OK107 line was a kind gift from Dr. L. Luo [26]. UAS-nlsGFP and elav-GAL4c155 flies were obtained from the Bloomington Drosophila Stock Center. For Pavlovian olfactory conditioning, the elav-GAL4c155 line was outcrossed with w1118 (isoCJ1) flies, an isogenic line, for 5 generations. Genotypes of flies used in this study are as follows: Control; elav-GAL4c155/Y, Abeta42; elav-GAL4c155/Y;; UAS-Abeta42/+, Abeta42Arc; elav-GAL4c155/Y;; UAS-Abeta42Arc/+ and Abeta42art; elav-GAL4c155/Y;; UAS-Abeta42art/+. In figure 3G, H and I, flies' genotypes are as follows: Control; w/Y;UAS-CD8::GFP/+;;OK107/+, Abeta42; w/Y; UAS-CD8::GFP/+;UAS-Abeta42/+;OK107/+, Abeta42Arc; w/Y; UAS-CD8::GFP/+;UAS-Abeta42Arc/+;OK107/+ and Abeta42art; w/Y; UAS-CD8::GFP/+;UAS-Abeta42art/+;OK107/+.
###end p 30
###begin title 31
Western blot and dot blot analysis
###end title 31
###begin p 32
For sequential extractions, fly heads were homogenized in RIPA buffer (50 mM Tris-HCl, pH 8.0, 0.5% sodium deoxycholate, 1% Triton X-100, 150 mM NaCl) containing 1% SDS. Lysates were centrifuged at 100,000 g for 1h, and supernatants were collected (SDS-soluble fraction). SDS-insoluble pellets were further homogenized in 70% formic acid (Sigma) followed by centrifugation at 13,000 rpm for 20 min and the supernatants were collected (FA fraction). Formic acid was evaporated by Speed Vac (Savant, SC100) and protein was resuspended in dimethyl sulfoxiside (Sigma).
###end p 32
###begin p 33
Protein extracts were immunoprecipitated with the anti-Abeta antibody 6E10 (Signet), separated on 10-20% Tris-Tricine gels (Invitrogen), and transferred to nitrocellulose membranes (Invitrogen). The membranes were boiled in phosphate buffered saline (PBS) for 3 min, blocked with 5% non-fat dry milk (Nestle) and blotted with the 6E10 antibody or anti-tubulin antibody (Sigma). To quantify levels of expression of the Abeta peptide, heads from 1-2 dae flies were homogenized in Tris-Tricine sample buffer (Invitrogen), centrifuged at 13,000 rpm for 20 min and the supernatants were subjected to Western blotting, as described above. The signal intensity was quantified using ImageJ (NIH).
###end p 33
###begin p 34
For dot blot analysis, fly heads were homogenized in 2% SDS followed by centrifugation at 13,000 rpm for 10 min. The supernatants were applied to a nitrocellulose membrane and air-dried. The membranes were blocked with 5% non-fat dry milk (Nestle) and blotted with the A11 (Invitrogen) or 6E10 antibodies (Signet).
###end p 34
###begin title 35
Immunoprecipitation and mass spectrometric analysis
###end title 35
###begin p 36
Two hundred Abeta fly heads were homogenized in 70% formic acid (Sigma) followed by centrifugation at 13,000 rpm for 20 min. The supernatant was evaporated using a Speed Vac (Savant, SC100) and protein was resuspended in dimethyl sulfoxiside (Sigma). The Abeta peptides were immunoprecipitated with the 6E10 antibody (Signet) and Protein-G Sepharose beads. The beads were washed three times with washing buffer (140 mM NaCl, 10 mM Tris-HCl, pH 8.0) containing 0.1% Octyl beta-D-glucopyranoside, and the peptides were eluted with 70% formic acid and subjected to MALDI-TOF mass spectrometry.
###end p 36
###begin title 37
Climbing assay
###end title 37
###begin p 38
Approximately 25 flies were placed in an empty plastic vial. The vial was gently tapped to knock the flies to the bottom and the number of flies at the top, middle, or bottom of the vial was scored after 10 seconds under red light (Kodak, GBX-2, Safelight Filter). Experiments were repeated more than three times, and a representative result was shown.
###end p 38
###begin title 39
Survival assay
###end title 39
###begin p 40
Food vials containing 25 flies were placed on their sides at 25degreesC, under conditions of 70% humidity and a 12 h:12 h light:dark cycle. Food vials were changed every 2-3 days, and the number of dead flies was counted each time. At least four vials for each genotype were prepared. Experiments were repeated more than three times, and a representative result was shown.
###end p 40
###begin title 41
Pavlovian olfactory associative learning
###end title 41
###begin p 42
###xml 104 106 104 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 143 145 143 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001703-Tully1">[23]</xref>
###xml 817 818 811 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 855 856 849 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
Approximately 100 flies were trained by exposure to electroshock paired with one odour [octanol (OCT, 10-3(v/v)) or methylcyclohexanol (MCH, 10-3(v/v))] for 60 s and subsequent exposure to the other odour without electroshock for 60 s [23]. Immediately after training, learning was measured by allowing flies to choose between the two odours for 120 s. For one hour memory, trained flies were transferred to food vials, which were placed on their side in the dark at 25degreesC and 70% humidity, and tested after one hour. The performance index (PI) was calculated by subtracting the number of flies making the incorrect choice from those making the correct one, dividing by the total number of flies, and multiplying by 100. Absolute odour avoidance was quantified by a T-maze with one of the two odours (octanol [103 (vol/vol)] or methylcyclohexanol [103 (vol/vol)]) coming from one side and air from the other side. Naive flies avoid odours, and the performance index was calculated by subtracting the number of flies that chose the odour side of the T-maze from those in the air side, dividing by the total number of flies and multiplying by 100. Electric shock reactivity was tested by putting approximately 100 flies in a T-maze having one arm with electric shock and one arm without electric shock. The performance index was calculated by subtracting the number of flies that chose the electric shock arm of the T-maze from those in the arm without shock, dividing by the total number of flies and multiplying by 100.
###end p 42
###begin title 43
Quantification of neurodegeneration
###end title 43
###begin p 44
###xml 882 901 878 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UAS-CD8::GFP;;OK107</italic>
Heads were fixed in 4% paraformaldehyde (Electron Microscopy Sciences), processed to embed in paraffin blocks, and sectioned at a thickness of 6 microm. Sections were placed on slides, stained with haematoxylin and eosin (Vector), and examined by bright-field microscopy. To quantify neurodegeneration in the cell body and neuropil of the mushroom body structures, images of the sections which included the Kenyon cell body and/or Calyx were captured, and the area of the vacuoles in the Kenyon cell body or Calyx region was measured in each image. The ratio was calculated by dividing the sum of the vacuole areas by the total area of the Kenyon cell body or Calyx region. Seven to nine hemispheres from five flies were analyzed for each genotype. To quantify the atrophy of dendritic and axonal structures of the mushroom body neurons, the GFP signal in whole fly brains carrying UAS-CD8::GFP;;OK107 was analyzed using confocal microscopy (Carl Zeiss LSM 510). The area of Calyxes (dendritic structures of the Kenyon cells), Lobes (axon bundles of the Kenyon cells) and the size of the brains was measured using LSM Image software. Six hemispheres from three flies were quantified for each genotype.
###end p 44
###begin title 45
Whole-mount immunostaining and Thioflavin S staining
###end title 45
###begin p 46
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 402 406 <span type="species:ncbi:9925">goat</span>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
###xml 682 686 <span type="species:ncbi:9925">goat</span>
###xml 692 697 <span type="species:ncbi:10090">mouse</span>
Fly brains were dissected in cold PBS and fixed in PBS containing 4% paraformaldehyde (EMS), and then placed under vacuum in PBS containing 4% paraformaldehyde and 0.25% Triton X-100. After permeabilization with PBS containing 2% Triton X-100, the brains were treated with 70% formic acid (Sigma), and stained with a mouse monoclonal anti-Abeta antibody (Chemicon) followed by detection with biotin-XX goat anti-mouse IgG and streptavidin-Oregon Green 488 conjugate (Molecular Probes). Nuclei were counterstained with propidium iodide (Molecular Probes). To detect nuclei of glial cells, fly heads were stained with an anti-Repo antibody (DSHB) followed by detection with Texas Red goat anti-mouse IgG (Molecular Probes). The brains were analyzed using a confocal microscope (Carl Zeiss LSM 510). For Thioflavin S (TS) staining, the brains were permeabilized and incubated in 50% EtOH containing 0.1% TS (Sigma) overnight. After washing in 50% EtOH and PBS, the brains were analyzed using a confocal microscope. TS-positive deposits and neurites were quantified from six hemispheres from three flies per genotype.
###end p 46
###begin title 47
Congo-Red staining
###end title 47
###begin p 48
###xml 252 257 <span type="species:ncbi:3750">Apple</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
Heads were fixed in 4% paraformaldehyde, processed to embed in paraffin blocks, and sectioned at a thickness of 10 microm. Sections were placed on slides and stained with an amyloid stain, Congo Red kit (Sigma), following the manufacuturer's protocol. Apple-green birefringence was examined by bright-field microscopy with a polarizing filter (Leica). Slides of human kidney tissue containing intracellular amyloid (Sigma) were processed at the same time as positive controls.
###end p 48
###begin title 49
Immuno-gold labelling and electron microscopy
###end title 49
###begin p 50
###xml 1033 1039 <span type="species:ncbi:9986">rabbit</span>
###xml 1062 1067 <span type="species:ncbi:9606">human</span>
###xml 1327 1331 <span type="species:ncbi:9925">goat</span>
###xml 1337 1343 <span type="species:ncbi:9986">rabbit</span>
Probosces were removed from decapitated heads, which were then immersion-fixed overnight in 4% glutaraldehyde and 2% paraformaldehyde in 0.1 M PBS. Samples were post-fixed 1 h in ferrocyanide-reduced osmium tetroxide (1% osmium tetroxide and 1.5% potassium ferrocyanide). Fixation was followed by dehydration in a graded alcohol series and infiltration with LR White resin (2 h in 50% LR White in ethanol and 24 h in 100% LR White) using constant rotation. After transferring the samples to gelatin capsules with fresh LR White resin, the samples were polymerized overnight at 60degreesC. Thin sections (100 nm) of Kenyon cells and neuropil regions of the mushroom body were collected on nickel grids (100 mesh, Veco-EMS). For immunogold labelling of Abeta42 transgenic and control fly heads, thin sections were first incubated for 2 minutes in 10% hydrogen peroxide for antigen retrieval, jet-rinsed in distilled water, and then placed on drops of 1% deacetylated BSA in PBS for 5 min. The grids were then transferred to drops of a rabbit antibody specific for human Abeta42 (Chemicon-Millipore) diluted 1:10 in PBS and incubated for 2 h at room temperature. Unbound primary antibody was removed by rinsing the grids through 5 drops of PBS. Antibody was detected by incubating grids for 1 h in 10 nm colloidal gold conjugated goat anti-rabbit H&L (GE Healthcare) diluted 1:10 in PBS. Grids were then rinsed in 10 drops of distilled water and air-dried. Thin sections were counterstained for 5 minutes in 3% uranyl acetate dissolved in 30% ethanol and then rinsed in distilled water.
###end p 50
###begin title 51
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
Drosophila S2 cell culture
###end title 51
###begin p 52
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 71 81 71 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 223 233 223 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actin-Gal4</italic>
###xml 238 247 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UAS-A&#946;</italic>
Drosophila Schneider's cells (S2 cells) were maintained in Schneider's Drosophila Medium (Gibco) supplemented with 10% FBS (GEMINI) and an Antibiotic-Antimycotic mixture (Gibco). The cells were transiently transfected with Actin-Gal4 and UAS-Abeta plasmid constructs using a calcium phosphate transfection kit (Invitrogen). Culture medium was replaced at 12 h post-transfection, and cells were cultured for an additional 24 h. The cells and culture medium were then harvested and subjected to immunoprecipitation followed by Western blot analysis as described above.
###end p 52
###begin title 53
Supporting Information
###end title 53
###begin p 54
MS/IP analysis of Abeta peptides expressed in fly brains. Each Abeta peptide was immunoprecipitated using the anti-Abeta antibody and subjected to MALDI-TOF mass spectrometry. Abeta42 (A), Abeta42Arc (B), and Abeta42art (C) were each detected at their predicted mass.
###end p 54
###begin p 55
(0.98 MB PDF)
###end p 55
###begin p 56
Click here for additional data file.
###end p 56
###begin p 57
Secretion of Abeta peptides expressed in Drosophila S2 cells. The levels of Abeta42 (blue), Abeta42Arc (magenta), and Abeta42art (green) in the culture medium were detected by Western blotting, normalized to intracellular Abeta levels, and shown as a ratio relative to that of Abeta42. Each Abeta peptide was secreted at different levels. Asterisks indicate a significant difference from Abeta42 (n = 3, P<0.05, Student's t-test).
###end p 57
###begin p 58
(0.08 MB PDF)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin p 60
Glial cells accumulate Abeta42 peptide produced in neurons in the Drosophila brain. ImmunoEM analysis detected Abeta42 (gold particles, arrowhead) in glial cells in brains of 25 dae flies with Abeta42 expression driven by elav-Gal4c155 (D). Scale bar in D: 1 microm. Confocal analysis revealed that elav-Gal4c155 does not drive the expression of transgene in glial cells. All nuclei of neurons in the fly brain were labeled by GFP fused to a nuclear localization signal driven by elav-Gal4c155 (A, green). The brain was counterstained with anti-Repo, a marker for Drosophila glial cells (B, magenta). The overlay image showed no significant overlap between the two signals (C). Scale bar in A, 50 microm.
###end p 60
###begin p 61
(3.82 MB PDF)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
###xml 697 706 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1B</xref>
###xml 793 801 761 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001703.s009">table S1</xref>
###xml 890 899 849 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001703-g001">Figure 1B</xref>
Behavioral defects induced by the expression of Abeta42, Abeta42Arc, and Abeta42art peptides were dose dependent. A, C and E, Locomotor dysfunction in independent transgenic lines (W; weak, M; moderate, S; strong expression) of Abeta42 (A), Abeta42Arc (C), and Abeta42art (E). The percent of flies at the top (yellow), middle (magenta), or bottom (blue) of the vial at 10 seconds after knocking flies to the bottom are shown (average+/-SEM (n = 10)). B, D and F, The percent survivorship of independent transgenic lines (W, M, and S) of Abeta42 (B), Abeta42Arc (D), and Abeta42art (F) was plotted against the age (dae). The expression levels of Abeta peptides in all transgenic lines are shown in Figure 1B, and indicated as S (strong), M (moderate) or W (weak). The results are summarized in table S1. In the main text, the data from Abeta42 M, Abeta42Arc M and Abeta42art M (asterisks in Figure 1B) are presented.
###end p 63
###begin p 64
(0.40 MB PDF)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
No A11-positive Abeta oligomers in Abeta42, Abeta42Arc, and Abeta42art fly brains. Fly brain lysates (1 or 2 microl) were applied on membrane and probed with 6E10 (top) or oligomer-specific antibody, A11 (bottom). No specific signal was observed with A11 antibody (top, compare Control and Abeta42Arc, Abeta42 or Abeta42art), while 6E10 detected Abeta in fly brains (bottom, compare Control and Abeta42Arc, Abeta42 or Abeta42art). elav-Gal4c155 flies were used as control.
###end p 66
###begin p 67
(1.61 MB PDF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
Learning defects in Abeta42, Abeta42Arc, and Abeta42art flies. Learning ability was assessed by Pavlovian olfactory conditioning at 10 dae. Asterisks indicate a significant difference from control (n = 6-8, alpha<0.05, Tukey-Kramer significant difference). Average learning scores+/-SEM are shown.
###end p 69
###begin p 70
(0.04 MB PDF)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
Brain sizes of control, Abeta42, Abeta42Arc, and Abeta42art flies were not significantly different. The thickness of fly brains was measured as indicated, and presented as average+/-SEM (n = 5 individual flies). The age of the flies is indicated at the bottom.
###end p 72
###begin p 73
(0.62 MB PDF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 429 434 <span type="species:ncbi:3750">apple</span>
The majority of Abeta aggregates in fly brains are not stained by Congo-Red. Paraffin sections of brains of 25 dae control (B), Abeta42 (C), Abeta42Arc (D) and Abeta42art (E) flies were stained with Congo-Red. Sections from human kidney tissue containing intracellular amyloid were used as a positive control (A). Amyloid was observed as pink signals under bright field, and beta-pleated structures were detected as birefringent apple-green signals using a polarizing filter (arrows in (A)). None of Abeta fly brains were stained with Congo-Red (C-E). The numerous vacuoles in (C-E) indicate neurodegeneration. For this analysis, transgenic lines with the highest expression of each Abeta peptide (Abeta42 S, Abeta42Arc M and Abeta42art S) were used.
###end p 75
###begin p 76
(7.67 MB PDF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
Summary of the characterization of Abeta transgenic lines. Asterisks (*) indicate transgenic lines primarily used in this study.
###end p 78
###begin p 79
(0.08 MB PDF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
Shock reactivity and olfactory acuity of transgenic flies at 10 dae. Abeta42, Abeta42Arc, and Abeta42art flies did not show any significant differences from control flies (n = 6, alpha<0.05, Tukey-Kramer significant difference). Average scores+/-SEM are shown. In MCH olfactory acuity of males, there were no differences relative to controls, but Abeta42Arc and Abeta42art flies were significantly different from each other (*).
###end p 81
###begin p 82
(0.18 MB PDF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
###xml 275 285 275 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
We thank L. Bianco and the CSHL animal facility for preparation of paraffin sections, M. Myers for Mass spectrometry analysis. We also thank J. Jaynes and D. Merry for helpful comments on the manuscript, L. Luo, the Bloomington stock center and the fly community at CSHL for Drosophila stocks.
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
Alzheimer's disease: genes, proteins, and therapy.
###end article-title 86
###begin article-title 87
The development of amyloid beta protein deposits in the aged brain.
###end article-title 87
###begin article-title 88
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.
###end article-title 88
###begin article-title 89
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.
###end article-title 89
###begin article-title 90
Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt.
###end article-title 90
###begin article-title 91
A century-old debate on protein aggregation and neurodegeneration enters the clinic.
###end article-title 91
###begin article-title 92
Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation.
###end article-title 92
###begin article-title 93
Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.
###end article-title 93
###begin article-title 94
Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
###end article-title 94
###begin article-title 95
Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.
###end article-title 95
###begin article-title 96
Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease.
###end article-title 96
###begin article-title 97
Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.
###end article-title 97
###begin article-title 98
To be or not to be toxic: aggregations in Huntington and Alzheimer disease.
###end article-title 98
###begin article-title 99
###xml 39 44 <span type="species:ncbi:9606">human</span>
Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease.
###end article-title 99
###begin article-title 100
Small non-fibrillar assemblies of amyloid beta-protein bearing the Arctic mutation induce rapid neuritic degeneration.
###end article-title 100
###begin article-title 101
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 42 47 <span type="species:ncbi:9606">human</span>
Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation.
###end article-title 101
###begin article-title 102
###xml 111 126 <span type="species:ncbi:10090">transgenic mice</span>
The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice.
###end article-title 102
###begin article-title 103
Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement.
###end article-title 103
###begin article-title 104
In vivo aggregation of beta-amyloid peptide variants.
###end article-title 104
###begin article-title 105
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.
###end article-title 105
###begin article-title 106
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis.
###end article-title 106
###begin article-title 107
###xml 91 114 <span type="species:ncbi:7227">Drosophila melanogaster</span>
On the relationship between senescence and age-related changes in two wild-type strains of Drosophila melanogaster.
###end article-title 107
###begin article-title 108
###xml 58 81 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Classical conditioning and retention in normal and mutant Drosophila melanogaster.
###end article-title 108
###begin article-title 109
Alzheimer's disease is a synaptic failure.
###end article-title 109
###begin article-title 110
Mushroom body memoir: from maps to models.
###end article-title 110
###begin article-title 111
Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system.
###end article-title 111
###begin article-title 112
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Genetic and environmental modifiers of Alzheimer's disease phenotypes in the mouse.
###end article-title 112
###begin article-title 113
Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.
###end article-title 113
###begin article-title 114
Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila.
###end article-title 114
###begin article-title 115
Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.
###end article-title 115
###begin article-title 116
Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells.
###end article-title 116
###begin article-title 117
A detergent-insoluble membrane compartment contains A beta in vivo.
###end article-title 117
###begin article-title 118
Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture.
###end article-title 118
###begin article-title 119
Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42.
###end article-title 119
###begin article-title 120
p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo.
###end article-title 120
###begin article-title 121
Attacking amyloid.
###end article-title 121
###begin article-title 122
Amyloid fibrillogenesis: themes and variations.
###end article-title 122
###begin article-title 123
ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.
###end article-title 123
###begin article-title 124
###xml 117 132 <span type="species:ncbi:10090">transgenic mice</span>
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
###end article-title 124
###begin article-title 125
Opposing activities protect against age-onset proteotoxicity.
###end article-title 125
###begin article-title 126
Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis.
###end article-title 126
###begin article-title 127
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host.
###end article-title 127
###begin article-title 128
The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila.
###end article-title 128
###begin p 129
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 129
###begin p 130
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Alzheimer's Association (to K.I.), Pilot Research Award from Thomas Jefferson University (to K.I.), the Hereditary Disease Foundation (to K.I.-A.), the start-up funds from Farber Institute for Neurosciences (to K.I. and K. I.-A. ), and the National Institutes of Health (to Y.Z.).
###end p 130

